The Editor's Roundtable: Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk

r. Friedewald receives honoraria for speaking from Noartis, East Hanover, New Jersey. Dr. Bennett receives ayment as a litigation expert from Weitz & Luxenburg, C, New York, New York. Dr. Packer receives payment as itigation expert from Pfizer, New York, New York. Dr. oberts receives honoraria for speaking from AstraZeneca, ilmington, Delaware; Merck, Whitehouse Station, New ersey; Novartis; and Schering-Plough, Kenilworth, New ersey. Dr. Williams receives honoraria for speaking and ontract payments for clinical trials from and is a consultant or the preparation and presentation of a science advisory to he United States District Court for Pfizer.